While prior research has primarily focused on the anti-tumor activities of IFN-α, studies have reported that the direct anti-tumor effects of IFN-β are much stronger, and elicited at much lower concentrations, as compared to IFN-α [16, 17]. Here, IFNB1 is linked to neoplasm.